Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Azithromycin Market Price & Analysis > Market Insights - Azithromycin > Inner Mongolia Jiupeng Pharmaceutical Co., Ltd. invested 1 billion yuan in the third phase of the construction of azithromycin, tetracycline and other API projects
— Share —

Inner Mongolia Jiupeng Pharmaceutical Co., Ltd. invested 1 billion yuan in the third phase of the construction of azithromycin, tetracycline and other API projects

healthoo 2021-09-15
Inner Mongolia Jiupeng Pharmaceutical Co., Ltd. has invested a total of 3.5 billion yuan in Kailu to build corn biotechnology and biomedical products projects in three phases.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.